Literature DB >> 17389125

Neuropsychiatric and behavioral aspects of trisomy 21.

Jeannie Visootsak1, Stephanie Sherman.   

Abstract

Down syndrome (DS), or trisomy 21, is the most common identifiable genetic cause of mental retardation. The syndrome is unique with respect to its cognitive, behavioral, and psychiatric profiles. The well-known cheerful and friendly demeanor often creates a personality stereotype, with parents and observers commenting on the positive attributes. Despite these strengths, approximately 20% to 40% of children with DS have recognized behavioral problems. Such problems persist through adulthood, with a decrease in externalizing symptoms of aggressiveness and attention problems and the emergence of internalizing symptoms of depression and loneliness. In adulthood, the presence of early-onset dementia of the Alzheimer type and cognitive decline may pose a challenge in recognizing these internalizing symptoms. Understanding the age-related changes in cognitive functioning and behavioral profiles in individuals with DS provides insight into clinical and treatment implications.

Entities:  

Mesh:

Year:  2007        PMID: 17389125     DOI: 10.1007/s11920-007-0083-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  44 in total

1.  Craniofacial maturity and perceived personality in children with Down syndrome.

Authors:  D J Fidler; R M Hodapp
Journal:  Am J Ment Retard       Date:  1999-09

2.  Expressive vocabulary ability of toddlers with Williams syndrome or Down syndrome: a comparison.

Authors:  C B Mervis; B F Robinson
Journal:  Dev Neuropsychol       Date:  2000       Impact factor: 2.253

Review 3.  Down syndrome and genetics - a case of linked histories.

Authors:  David Patterson; Alberto C S Costa
Journal:  Nat Rev Genet       Date:  2005-02       Impact factor: 53.242

Review 4.  Trisomy 21: from chromosomes to mental retardation.

Authors:  Pierre L Roubertoux; Bernard Kerdelhué
Journal:  Behav Genet       Date:  2006-04-05       Impact factor: 2.805

5.  Maladaptive behaviours and symptoms of dementia in adults with Down's syndrome compared with adults with intellectual disability of other aetiologies.

Authors:  S A Cooper; V P Prasher
Journal:  J Intellect Disabil Res       Date:  1998-08

6.  Sleep characteristics in children with Down syndrome.

Authors:  A Levanon; A Tarasiuk; A Tal
Journal:  J Pediatr       Date:  1999-06       Impact factor: 4.406

7.  Differential rates of psychiatric disorders in adults with Down's syndrome compared with other mentally handicapped adults.

Authors:  R A Collacott; S A Cooper; C McGrother
Journal:  Br J Psychiatry       Date:  1992-11       Impact factor: 9.319

8.  Maladaptive behaviour in children and adolescents with Down's syndrome.

Authors:  E M Dykens; B Shah; J Sagun; T Beck; B H King
Journal:  J Intellect Disabil Res       Date:  2002-09

9.  Spectrum of cognitive, behavioural and emotional problems in children and young adults with Down syndrome.

Authors:  R Nicham; R Weitzdörfer; E Hauser; M Freidl; M Schubert; E Wurst; G Lubec; R Seidl
Journal:  J Neural Transm Suppl       Date:  2003

10.  Psychiatric disorders in persons with Down syndrome.

Authors:  B A Myers; S M Pueschel
Journal:  J Nerv Ment Dis       Date:  1991-10       Impact factor: 2.254

View more
  9 in total

1.  Reliability of parent report measures of behaviour in children with Down syndrome.

Authors:  A J Esbensen; E K Hoffman; R Shaffer; E Chen; L Patel; L Jacola
Journal:  J Intellect Disabil Res       Date:  2018-07-18

2.  Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic mice.

Authors:  Jian Yan; Stephen D Ginsberg; Brian Powers; Melissa J Alldred; Arthur Saltzman; Barbara J Strupp; Marie A Caudill
Journal:  FASEB J       Date:  2014-06-24       Impact factor: 5.191

3.  A mental retardation gene, motopsin/neurotrypsin/prss12, modulates hippocampal function and social interaction.

Authors:  Shinichi Mitsui; Yoji Osako; Fumiaki Yokoi; Mai T Dang; Kazunari Yuri; Yuqing Li; Nozomi Yamaguchi
Journal:  Eur J Neurosci       Date:  2009-12-10       Impact factor: 3.386

4.  Using animal models of enriched environments to inform research on sensory integration intervention for the rehabilitation of neurodevelopmental disorders.

Authors:  Stacey Reynolds; Shelly J Lane; Lorie Richards
Journal:  J Neurodev Disord       Date:  2010-06-12       Impact factor: 4.025

5.  Catatonia in Down syndrome: systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients.

Authors:  Judith H Miles; Nicole Takahashi; Julie Muckerman; Kerri P Nowell; Muaid Ithman
Journal:  Neuropsychiatr Dis Treat       Date:  2019-09-20       Impact factor: 2.570

6.  An intervention targeting social, communication and daily activity skills in children and adolescents with Down syndrome and autism: a pilot study.

Authors:  Ulrika Wester Oxelgren; Joakim Westerlund; Åsa Myrelid; Göran Annerén; Lotta Johansson; Marie Åberg; Jan Gustafsson; Elisabeth Fernell
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-18       Impact factor: 2.570

7.  Capturing cognitive and behavioral variability among individuals with Down syndrome: a latent profile analysis.

Authors:  Marie Moore Channell; Laura J Mattie; Debra R Hamilton; George T Capone; E Mark Mahone; Stephanie L Sherman; Tracie C Rosser; Roger H Reeves; Luther G Kalb
Journal:  J Neurodev Disord       Date:  2021-04-19       Impact factor: 4.025

8.  Relationship Between Parent and Teacher Reported Executive Functioning and Maladaptive Behaviors in Children With Down Syndrome.

Authors:  Anna J Esbensen; Emily K Hoffman; Rebecca C Shaffer; Lina R Patel; Lisa M Jacola
Journal:  Am J Intellect Dev Disabil       Date:  2021-07-01

9.  Impact of COVID-19-Related Lockdown on Psychosocial, Cognitive, and Functional Well-Being in Adults With Down Syndrome.

Authors:  Emanuele Rocco Villani; Davide Liborio Vetrano; Cecilia Damiano; Antonella Di Paola; Aurora Maria Ulgiati; Lynn Martin; John P Hirdes; Laura Fratiglioni; Roberto Bernabei; Graziano Onder; Angelo Carfì
Journal:  Front Psychiatry       Date:  2020-10-28       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.